Similar Papers

Paper Title
Journal
Date
Author
Assessment of Silent Liver Fibrosis in Hemochromatosis C282Y Homozygotes With Normal Transaminase Levels
Melanie Beaton ... Paul C Adams
Clinical Gastroenterology and Hepatology | VOL. 6
Melanie Beaton, et. al.Melanie Beaton ... Paul C Adams
01 Jun 2008
Overall Survival of Nonmetastasized NSCLC Patients Treated With Add-On Viscum album L: A Multicenter Real-World Study
Anja Thronicke ... Christian Grah
Integrative Cancer Therapies | VOL. 19
Anja Thronicke, et. al.Anja Thronicke ... Christian Grah
01 Jan 2020
Concurrent transarterial chemoembolization plus atezolizumab and bevacizumab in unresectable hepatocellular carcinoma: Interim analysis from a multicenter real-world study (CHANCE 023).
Rong Yan ... Gao-Jun Teng
Journal of Clinical Oncology | VOL. 43
Rong Yan, et. al.Rong Yan ... Gao-Jun Teng
01 Feb 2025
Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study.
Chengpei Zhu ... Haitao Zhao
Cancer immunology, immunotherapy : CII | VOL. 72
Chengpei Zhu, et. al.Chengpei Zhu ... Haitao Zhao
29 May 2023
View more papers

More From: Journal of Hepatology

Paper Title
Journal
Date
Author
Introducing the Breakthrough Beyond the Journal series.
Vlad Ratziu
Journal of hepatology | VOL. 82
Vlad RatziuVlad Ratziu
01 Feb 2025
Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies
Homie A Razavi ... Eli Zuckerman
Journal of Hepatology | VOL. -
Homie A Razavi, et. al.Homie A Razavi ... Eli Zuckerman
01 Feb 2025
MICROB-PREDICT works on identifying microbiome-based predictors and mechanisms of decompensated liver cirrhosis & ACLF, and develop personalised treatment strategies. Discover the project!
-
Journal of Hepatology | VOL. 82
--
01 Feb 2025
Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m6A-regulated expression of a novel anti-fibrotic target ETV4
Xiaoyong Xue ... Xiaojiaoyang Li
Journal of Hepatology | VOL. -
Xiaoyong Xue, et. al.Xiaoyong Xue ... Xiaojiaoyang Li
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.